MaxCyte, Inc.

Healthcare · Medical Devices · United States

Last price 1.73 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 178.55M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engi...